Home
Exalenz Bioscience Ltd.

Exalenz Bioscience Ltd. Market Share Analysis for June 2026

Careers at Meridian Bioscience - find a job at Meridian Bioscience.

Industry: N/A

Domainexalenz.com

Year Founded2006

Employees51 - 200

Annual Revenue$10M - $15M

Exalenz Bioscience Ltd.

Exalenz Bioscience Ltd. (including company regionals)

exalenz.com

See more website traffic and engagement information

Exalenz Bioscience Ltd. Revenue up to June 2026 is 10M - 15M

revenue generated by Exalenz Bioscience Ltd. top domains

Exalenz Bioscience Ltd. top domains revenue over 3 years

Revenue for Exalenz Bioscience Ltd. top domains

exalenz.com10M - 15M

See more with Sales Intelligence

Total visits to Exalenz Bioscience Ltd.'s top domains

Understand Exalenz Bioscience Ltd. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

exalenz.com--

See more with Sales Intelligence

Avg. visit duration in Exalenz Bioscience Ltd.'s top domains

Analyze Exalenz Bioscience Ltd. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Exalenz Bioscience Ltd.'s top domains

See how Exalenz Bioscience Ltd. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

exalenz.com--

See more with Sales Intelligence

Exalenz Bioscience Ltd. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Exalenz Bioscience Ltd.

These are the website technologies, by industry, used by Exalenz Bioscience Ltd. top domains

Conversion & Analytics (5)

Google Analytics

Widget (4)

Twemoji

Marketing (3)

Google Marketing Platform

Advertising (2)

DoubleClick

More Technologies

8

See all

News & Signals from Exalenz Bioscience Ltd.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsMeridian Bioscience acquired Exalenz for $49M on Feb 19th '20.Meridian Bioscience, Inc. ( VIVO ) and Exalenz Bioscience Ltd. (TASE:EXEN) announced today that the two companies have entered into a definitive agreement for Meridian to acquire Exalenz for ₪6.10 per share in cash with an implied transaction value of approximately $49 million.

NewsExalenz hired Roy Golan CPA as President and Chief Financial Officer on Apr 30th '18.Exalenz Bioscience Ltd. (TASE:EXEN), a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of gastrointestinal and liver diseases, today announced the appointment of Roy Golan CPA, LLM as President and Chief Financial Officer.

NewsExalenz partnered with Conatus Pharmaceuticals Inc on Aug 29th '16.Exalenz Bioscience (TASE: EXEN), a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of gastrointestinal and liver diseases, today announced a collaboration with Conatus Pharmaceuticals Inc. (Nasdaq: CNAT ) to use the BreathID® Methacetin Breath Test (MBT) to monitor patients in a planned Phase IIb clinical trial evaluating emricasan.